【结 构 式】 |
【分子编号】15610 【品名】4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 【CA登记号】 |
【 分 子 式 】C8H11N3O3S 【 分 子 量 】229.25976 【元素组成】C 41.91% H 4.84% N 18.33% O 20.94% S 13.99% |
合成路线1
该中间体在本合成路线中的序号:(VI)There are two options for the synthesis of lamivudine: In the first approach the intact nucleoside analogue is prepared in racemic form by resolution to afford the required chiral product. This can be effected by an enzyme-mediated enantiospecific reaction. In the second approach synthesis of a chiral sugar component precedes coupling with the cytosine base under conditions where the chirality of the sugar precursor is maintained. The first approach is outlined in Scheme 18435601a. The oxathiolane (III) is obtained as a 1:1 mixture of anomers from reaction of benzoyloxyacetaldehyde (I) with mercaptoacetaldehyde dimethylacetal (II) in the presence of a Lewis acid. Treatment of (III) with silylated cytosine (IV) in the presence of TMS-triflate affords a 1:1 mixture of beta- and alpha-anomers (V) from which the required beta-anomer may be obtained by crystallization. Various alternative coupling conditions have been reported which yield almost exclusively the beta-anomer, notably as a result of the use of SnCl4. Subsequent deprotection affords the racemic nucleoside (VI) (BCH189). The resolution may be effected by a variety of enzymatic processes. Treatment of the nucleoside with phosphorus oxychloride and trimethylphosphate affords the 5'-monophosphate (VII). The natural enantiomer is selectively recognized by the 5'-nucleotidase from Crotalus atrox venom to afford the (+)-beta-D-nucleoside (VIII) and leave the unatural (-)-beta-L-enantiomer as the monophosphate (IX). Facile separation of these two products and subsequent dephosphorylation of (IX) using bacterial alkaline phosphatase affords lamivudine. Selective enzymatic recognition of the natural enantiomer may also be used to advantage in the resolution using cytidine deaminase derived from E. coli. In this case the enzyme is responsible for enantiospecific hydrolysis of the natural form to afford a readily separable mixture of lamivudine and the uridine derivative (X). Other enzymes including esterases and phosphodiesterases have application in the resolution of derivatives of the racemic nucleoside.
【1】 Choi, W.-B.; Yeola, S.; Liotta, D.C.; Wilson, L.S.; Schinazi, R.F.; In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of oxathiolanyl and dioxolanyl nucleoside analogues. J Am Chem Soc 1991, 113, 9377-9. |
【2】 Coates, J.A.V.; Mutton, I.M.; Penn, C.R.; Storer, R.; Williamson, C. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0625150; JP 1993501117; JP 1999080153; JP 2000128787; WO 9117159 . |
【3】 Belleau, B.; Nguyen-Ba, N. (BioChem Pharma Inc.); Substd.-1,3-oxathiolanes with antiviral properties. EP 0382526; EP 0711771; JP 1996119967; JP 2000143662; US 5047407 . |
【4】 Storer, R.; Belleau, B.; Noble, S.A.; Lamont, B.; Clemens, I.R.; Williamson, C.; The resolution and absolute stereochemistry of the enantiomers of cis-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (BCH189): Equipotent anti-HIV agents. Nucleosides Nucleotides 1993, 12, 2, 225. |
【5】 Storer, R.; Wilcox, P.; Daniel, M.; Collis, P.; Cameron, J.M.; Lamivudine. Drugs Fut 1993, 18, 4, 319. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 15605 | 2-oxoethyl benzoate | C9H8O3 | 详情 | 详情 | |
(II) | 15606 | 2,2-dimethoxy-1-ethanethiol; 2,2-dimethoxyethylhydrosulfide | C4H10O2S | 详情 | 详情 | |
(III) | 15607 | (5-methoxy-1,3-oxathiolan-2-yl)methyl benzoate | C12H14O4S | 详情 | 详情 | |
(IV) | 12706 | Cytosine; 4-Amino-2(1H)-pyrimidinone | 71-30-7 | C4H5N3O | 详情 | 详情 |
(V) | 15609 | [5-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl benzoate | C15H15N3O4S | 详情 | 详情 | |
(VI) | 15610 | 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone | C8H11N3O3S | 详情 | 详情 | |
(VII) | 15611 | [5-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl dihydrogen phosphate | C8H12N3O6PS | 详情 | 详情 | |
(VIII) | 15612 | 4-amino-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone | C8H11N3O3S | 详情 | 详情 | |
(IX) | 15613 | [(2R,5S)-5-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl dihydrogen phosphate | C8H12N3O6PS | 详情 | 详情 | |
(X) | 15614 | 1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione | C8H10N2O4S | 详情 | 详情 |